| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), NRXS's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 35.9K | $226.4K | - | |
| Dir | 33.9K | $213.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 23, 2025 | Aharon Gil62 | Director | Buy | 286,138 | $3.52 | $1,007,205.76 | New | +110.1% | - | |
| Jul 1, 2025 | Hannasch Brian72 | 10% Owner | Buy | 355,556 | $2.25 | $800,001.00 | +45.8% | +30.7% | +197.5% | |
| Apr 21, 2025 | Hannasch Brian72 | 10% Owner | Buy | 18,065 | $1.73 | $31,250.64 | +2.4% | +52.1% | - | |
| Dec 28, 2023 | Hannasch Brian72 | 10% Owner | Sell | 76 | $2.61 | $198.36 | - | +31.0% | -4.7% |